logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
J

John Mascarenhas

Tisch Cancer Institute

54H指数
704论文数
1.1W被引数
收录论文 133
发表时间
logo
Defining and predicting disease progression in myeloproliferative neoplasms: a proposed biomarker-driven approach定义和预测骨髓增殖性肿瘤的疾病进展：一种基于生物标志物驱动的方法
errLeukemia
IF13.4
err2026-09-01
err0
errOAAI
errRaajit K. Rampal; Richard Winneker; Andrew Kuykendall; Laura C. Michaelis; Ghaith Abu-Zeinah; Steffen Koschmieder; Jan Philipp Bewersdorf; Zi Yun Ng; Gabriella Hobbs; Bridget Marcellino; Linda Resar; Joseph Scandura; Anand Patel; John Mascarenhas; Aaron Gerds; Douglas Tremblay; Shane Mayack; Andriy Derkach; Florian H. Heidel
err分享
err收藏
Immunotherapeutic targeting of calreticulin mutant myeloproliferative neoplasms靶向钙网蛋白突变骨髓增殖性肿瘤的免疫疗法
errLeukemia
IF13.4
err2026-08-18
err0
errOAAI
errCharles Hertz; Nikolaos Spyrou; Ronald Hoffman; Cansu Cimen Bozkus; Nina Bhardwaj; Douglas Tremblay; Marina Kremyanskaya; John Mascarenhas
err分享
err收藏
Long term outcomes of idasanutlin therapy in hydroxyurea-refractory polycythemia vera patients伊达沙纳替林治疗羟基脲难治性真性红细胞增多症患者的长期结局
errLEUKEMIA & LYMPHOMA
IF2.2
err2026-07-29
err0
PREAI
errMetzger, Megan; Waksal, Julian A.; Jain, Jayanshu; Rosas, Natalia; Maffioli, Margherita; Van Hyfte, Grace; Gerds, Aaron; Gupta, Vikas; Passamonti, Francesco; Yacoub, Abdulraheem; Hoffman, Ronald; Mascarenhas, John O.
err分享
err收藏
Interferon in early MF: intersection of biology and evidence干扰素在早期MF中的生物学与证据的交叉点
errBlood Advances
IF7.1
err2026-06-04
err0
errOAAI
errJohn Mascarenhas
err分享
err收藏
A MICA/B GAALIE-mutant antibody elicits potent natural killer cell-driven immunity in solid and hematologic malignancy modelsMICA/B GAALIE突变抗体在实体瘤和血液系统恶性肿瘤模型中引发强烈的自然杀伤细胞介导的免疫应答
errCell Reports Medicine
IF10.6
err2026-04-17
err0
errOAAI
errRuan Pimenta; Stefanie Maurer; Xiaoxuan Zhong; Bruna Taciane da Silva Bortoleti; Sophia Quasem; Luiza Ribeiro de Lima Brandão; Bridget Marcellino; Anindita Dutta; Juan M. Arriaga; John Mascarenhas; Lucas Ferrari de Andrade
err分享
err收藏
SOHO State of the Art Updates and Next Questions | Is Combination Therapy Here for Myelofibrosis?SOHO 技术现状更新与下一阶段问题 | 难道针对骨髓纤维化的联合疗法已经到来？
errClinical Lymphoma Myeloma and Leukemia
IF2.7
err2026-04-08
err0
PREAI
errMegan Metzger; Charles Hertz; John Mascarenhas
err分享
err收藏
Phase 1b study of ABBV-744, a novel, selective BET inhibitor, as monotherapy in patients with myelofibrosis1b期研究：ABBV-744（一种新型选择性BET抑制剂）作为单药疗法在骨髓纤维化患者中的应用
errBlood Advances
IF7.1
err2026-03-19
err0
errOAAI
errJohn Mascarenhas; Laura Fogliatto; Steven Green; Ignacio Corvalan; Elie Traer; Keita Kirito; Hun Chuah; Kazuki Sakatoku; Rasmus Hoeg; Mohamad Khawandanah; David Lavie; Zoë Hunter; David Quinn; Yizhuo Wang; Jason Harb; Jiuhong Zha; Uriel Malyankar; Ellen Ritchie
err分享
err收藏
Sequential treatment with ruxolitinib and imetelstat effectively depletes myelofibrosis hematopoietic stem and progenitor cells鲁索替尼和伊美司他序贯治疗可有效消耗骨髓纤维化造血干细胞和祖细胞
errLeukemia
IF13.4
err2026-02-03
err0
PREAI
errXiaoli Wang; Andrew Davis; Cing Siang Hu; Fei Huang; Sophia Jiang; John Mascarenhas; Ronald Hoffman
err分享
err收藏
Interferon alpha in myeloproliferative neoplasms: evidence and practical considerations for clinical care干扰素α在骨髓增殖性肿瘤中的应用：临床护理的证据和实践考量
errLEUKEMIA & LYMPHOMA
IF2.2
err2025-12-01
err0
PREAI
errMetzger, Megan; Mascarenhas, John
err分享
err收藏
European LeukemiaNet criteria for safety and efficacy evaluation of new drugs for myelofibrosis欧洲白血病网络联盟（European LeukemiaNet）关于新药在骨髓纤维化中安全性和有效性评估的标准
errBlood Cancer Journal
IF11.6
err2025-11-24
err0
errOAAI
errMonia Marchetti; Alessandro Maria Vannucchi; John O. Mascarenhas; Alberto Alvarez-Larran; Prithviraj Bose; Robert Peter Gale; Claire Harrison; Rűdiger Hehlmann; Jean-Jacques Kiladjian; Steffen Koschmieder; Ruben Mesa; Francesco Passamonti; Alessandro Rambaldi; Ayalew Tefferi; Tiziano Barbui
err分享
err收藏
ECLIPSE-PV: A Randomized, Multicenter Study to Assess Efficacy, Safety, and Tolerability of Two Dosing Regimens of Ropeginterferon Alfa-2b-Njft in Polycythemia Vera
errACTA HAEMATOLOGICA
IF1.1
err2025-11-01
err1
PREAI
errMascarenhas, John; Bose, Prithviraj; Hillis, Christopher; Yacoub, Abdulraheem; El Chaer, Firas; Maze, Dawn; Abu-Zeinah, Ghaith; Qin, Albert; Priego, Victor; Tashi, Tsewang; Cerquozzi, Sonia; Babu, Sunil; Foltz, Lynda; Goel, Swati; Bhave, Rupali R.; Lee, Stephanie; Oh, Stephen T.; Reeves, Brandi; Benton, Christopher; Fletcher, Luke; Sirhan, Shireen; Safah, Hana; Salib, Hayman; Villeneuve, Pierre J. A.; Zagrijtschuk, Oleh; Castro, Henry; Masarova, Lucia
err分享
err收藏
Early de-escalation of empiric antibiotic therapy in neutropenic fever: a single-center, retrospective study
errANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY
IF1.8
err2025-10-30
err0
errOAAI
errMostel, Zachary; Evans, Michelle; Tremblay, Douglas; Rana, Meenakshi; Jacobs, Samantha E.; Mascarenhas, John; Keyzner, Alla; Park, Daniel; Fuller, Risa
err分享
err收藏
Results from a US modified Delphi consensus to define disease progression and disease modification in polycythemia Vera来自美国改良德尔菲共识的结果，用于定义真性红细胞增多症中的疾病进展和疾病修饰。
errAnnals of Hematology
IF2.4
err2025-10-15
err0
errOAAI
errPrithviraj Bose; Emily Nagler; Muhammad Sarfraz Nawaz; Raajit K. Rampal; Tsewang Tashi; Swapna Thota; John O. Mascarenhas
err分享
err收藏
Distinct Characteristics of Lymphoid and Myeloid Clonal Hematopoiesis in World Trade Center First Responders世界贸易中心一线救援人员中淋巴细胞和髓系克隆性造血的特异特征
errAmerican Journal of Hematology
IF9.9
err2025-07-29
err0
PREAI
errMyvizhi Esai Selvan; Pei-Fen Kuan; Xiaohua Yang; John Mascarenhas; Robert J. Klein; Benjamin J. Luft; Paolo Boffetta; Zeynep H. Gümüş
err分享
err收藏
Target practice: Opportunities for therapeutic intervention in CHIP and CCUS目标练习：CHIP和CCUS的干预机会
errBlood Reviews
IF5.7
err2025-07-25
err0
PREAI
errAyman Mohammad; John Mascarenhas; Bridget K. Marcellino; Daniel I. Nathan
err分享
err收藏
Thrombocytopenia in myelofibrosis is characterized by inflammatory megakaryocytes with reduced G6B expression原发性骨髓纤维化中的血小板减少症以炎症性巨核细胞为特征，其G6B表达降低。
errBlood
IF23.1
err2025-07-14
err0
PREAI
errLilian Varricchio; Gohar Mosoyan; Sebastian Elghaity-Beckley; Md. Babu Mia; Shivani Handa; Christian Salib; John Mascarenhas; Ronald Hoffman
err分享
err收藏
Highlights from MPN Asia 2025: Advances in Molecular Pathogenesis and Therapeutic Strategies in Myeloproliferative NeoplasmsMPN Asia 2025亮点：髓系增殖性肿瘤的分子发病机制和治疗策略进展
errCurrent Hematologic Malignancy Reports
IF3.3
err2025-07-12
err0
errOAAI
errPrithviraj Bose; Zhijian Xiao; Hans C. Hasselbalch; Josef T. Prchal; Minghui Duan; Abdulraheem Yacoub; Raajit Rampal; Jean-Jacques Kiladjian; Gabriela S. Hobbs; Tsewang Tashi; Kazuya Shimoda; Keita Kirito; Harinder Gill; Hsin-An Hou; Sung-Eun Lee; Jian Huang; Bing Li; Albert Qin; Lennex Hsueh-Lin Yu; John O. Mascarenhas; Ruben A. Mesa
err分享
err收藏
Polycythaemia vera
errNature Reviews Disease Primers
IF60.6
err2025-04-17
err0
PREAI
errHarrison, Claire N.; Barbui, Tiziano; Bose, Prithviraj; Kiladjian, Jean-Jacques; Mascarenhas, John; McMullin, Mary Frances; Mesa, Ruben; Vannucchi, Alessandro M.
err分享
err收藏
Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis: a randomized phase 3 trialPelabresib联合ruxolitinib治疗JAK抑制剂初治骨髓纤维化：一项随机III期试验
errNATURE MEDICINE
IF50
err2025-03-10
err2
errOAAI
errRampal, Raajit K.; Grosicki, Sebastian; Chraniuk, Dominik; Abruzzese, Elisabetta; Bose, Prithviraj; Gerds, Aaron T.; Vannucchi, Alessandro M.; Palandri, Francesca; Lee, Sung-Eun; Gupta, Vikas; Lucchesi, Alessandro; Oh, Stephen T.; Kuykendall, Andrew T.; Patriarca, Andrea; alvarez-Larran, Alberto; Mesa, Ruben; Kiladjian, Jean-Jacques; Talpaz, Moshe; Scandura, Joseph M.; Lavie, David; Harris, Morgan; Kays, Sarah-Katharina; Li, Qing; Boxhammer, Rainer; Brown, Barbara; Jegg, Anna-Maria; Harrison, Claire N.; Mascarenhas, John
err分享
err收藏
Fedratinib in 2025 and beyond: indications and future applicationsFedratinib在2025年及以后：适应症和未来应用
errBLOOD ADVANCES
IF7.1
err2025-02-14
err1
errOAAI
errColtoff, Alexander; Mascarenhas, John
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
P
Paolo Boffetta
H 指数: 167 · 论文数: 2.1K
A
Ayalew Tefferi
H 指数: 152 · 论文数: 2.1K
G
Guillermo Garcia‐Manero
H 指数: 149 · 论文数: 2.9K
R
Richard E. Champlin
H 指数: 147 · 论文数: 2.1K
R
Ross L. Levine
H 指数: 147 · 论文数: 1.5K
查看更多